Susquehanna International Group’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
Other funds holding TTNP
TRCT
MA
GWSA
NRG
Susquehanna International Group's TTNP Position: Q1 2024 in Review
Susquehanna International Group sold out of Titan Pharmaceuticals (TTNP) in Q1 2024, closing a stake of 980 shares — an estimated $8.08K sold.
Susquehanna International Group first reported a position in TTNP in Q3 2016 and held it in 13 quarters. The position peaked at $203K in Q4 2016. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2024.
- Susquehanna International Group reported no remaining Titan Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Susquehanna International Group sold 980 Titan Pharmaceuticals shares in Q1 2024, an estimated $8.08K.
- Susquehanna International Group first reported a position in Titan Pharmaceuticals in Q3 2016 and held it in 13 quarters.
- Susquehanna International Group's Titan Pharmaceuticals position peaked at $203K in Q4 2016.
- 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2024.
Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.